This chemical is primarily used in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. Its structure, featuring a fluoropiperidine moiety, makes it valuable for creating compounds with enhanced bioavailability and metabolic stability. Additionally, it is utilized in the preparation of potential therapeutic agents for conditions such as depression, anxiety, and other central nervous system-related diseases. Its application extends to research and development, where it serves as a building block for exploring novel drug candidates with improved efficacy and safety profiles.